These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7301655)

  • 41. [Acid phosphatase (ACP)].
    Igawa M; Kishi H; Ishibe T
    Nihon Rinsho; 1995 May; 53(5):1203-8. PubMed ID: 7602779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
    Shih WJ; Wierzbinski B; Collins J; Magoun S; Chen IW; Ryo UY
    J Nucl Med; 1990 Sep; 31(9):1486-9. PubMed ID: 1697617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alkaline phosphatase isoenzyme patterns in malignant disease.
    Van Hoof VO; Van Oosterom AT; Lepoutre LG; De Broe ME
    Clin Chem; 1992 Dec; 38(12):2546-51. PubMed ID: 1458597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain.
    Magnusson P; Larsson L; Englund G; Larsson B; Strang P; Selin-Sjögren L
    Clin Chem; 1998 Aug; 44(8 Pt 1):1621-8. PubMed ID: 9702948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
    Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
    Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)].
    Kida T; Higuchi Y
    Kaku Igaku; 1981 Aug; 18(7):907-15. PubMed ID: 7321322
    [No Abstract]   [Full Text] [Related]  

  • 47. The clinical use of alkaline phosphatase enzymes.
    Epstein E; Kiechle FL; Artiss JD; Zak B
    Clin Lab Med; 1986 Sep; 6(3):491-505. PubMed ID: 3527542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The distinction of bone and liver isoenzymes of alkaline phosphatase in serum using a monoclonal antibody.
    Seabrook RN; Bailyes EM; Price CP; Siddle K; Luzio JP
    Clin Chim Acta; 1988 Mar; 172(2-3):261-6. PubMed ID: 3370840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer.
    Gerber G; Chodak GW
    Urology; 1991 May; 37(5):418-22. PubMed ID: 2024388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Audit and its impact in the management of advanced prostatic cancer.
    Rana A; Chisholm GD; Christodoulou S; McIntyre M; Elton RA
    Br J Urol; 1993 Oct; 72(4):478-83. PubMed ID: 8261306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serial bone scanning: the assessment of treatment response in carcinoma of the prostate.
    Fitzpatrick JM; Constable AR; Sherwood T; Stephenson JJ; Chisholm GD; O'Donoghue EP
    Br J Urol; 1978 Dec; 50(7):555-61. PubMed ID: 753508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Electrophoretic demonstration of serum alkaline phosphatase isoenzymes in liver and bone diseases].
    Hosenfeld D
    Dtsch Med Wochenschr; 1978 Feb; 103(7):286-8. PubMed ID: 627186
    [No Abstract]   [Full Text] [Related]  

  • 54. Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
    Mackintosh J; Simes J; Raghavan D; Pearson B
    Br J Urol; 1990 Jul; 66(1):88-93. PubMed ID: 2203503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid serum screening test for increased osteoblastic activity.
    Kerkhoff JF
    Clin Chim Acta; 1968 Oct; 22(2):231-8. PubMed ID: 5687090
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
    Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
    Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase.
    Wolff JM; Ittel TH; Borchers H; Boekels O; Jakse G
    Anticancer Res; 1999; 19(4A):2653-5. PubMed ID: 10470213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
    Barichello M; Gion M; Bonazza A; Delli Ponti US; Bolgan A; Contemori GP; Barioli P; Capitanio G; Pecori B; Omacini S
    Eur Urol; 1995; 27(4):295-300. PubMed ID: 7544735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum osteocalcin concentration in patients with prostatic cancer.
    Francini G; Bigazzi S; Leone V; Gennari C
    Am J Clin Oncol; 1988; 11 Suppl 2():S83-7. PubMed ID: 3266542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Practical method for determination of isophosphatase in the human serum].
    Chirillo R; Fornasiero C
    Quad Sclavo Diagn; 1973 Mar; 9(1):103-14. PubMed ID: 4788703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.